Sabacajan, Marjorie .

HRN: 22-20-05  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2022
CEFUROXIME 1.5GM (VIAL)
12/21/2022
12/27/2022
IV
1.5gm
Q8
S/P LTCS
Waiting Final Action 
12/22/2022
CEFUROXIME 500MG (TAB)
12/22/2022
12/28/2022
ORAL
500mg
BID
S/p Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: